Effect of Change to a Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimen of Efavirenz (EFV) and Lopinavir/Ritonavir (LPV/r) on Liver Histology in HIV-1-Infected Individuals With Lactic Acidemia and Persistent Alanine Aminotransferase (ALT) Elevations on NRTI-Containing Antiretroviral Therapy.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 25 Feb 2011
At a glance
- Drugs Efavirenz (Primary) ; Lopinavir/ritonavir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 11 Oct 2008 New trial record.